2766-0125

eGastroenterology

BMJ

View prefix report (10.1136)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 21 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact21 DOIs
2

Attach ORCID iDs across 12 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact12 DOIs
3

Deposit reference lists for 5 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact5 DOIs

DOIs for this ISSN

Showing the top 5 of 113 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Future directions in the microbiome field: an editor’s persp… (10.1136/egastro-2023-100003)
Abstract References ORCID
58.36 5
2 First release of Mendelian randomisation book in Chinese (10.1136/egastro-2023-100043)
Abstract References
50.00 9
3 Spatial dimension of macrophage heterogeneity in liver disea… (10.1136/egastro-2023-000003)
ORCID
38.91 35
4 Two years on, a perspective on MAFLD (10.1136/egastro-2023-100019)
ORCID
34.95 24
5 Recent insights into the pathogenesis and therapeutic target… (10.1136/egastro-2023-100020)
ORCID
34.04 22
6 Gut microbiota and immune alteration in cancer development:… (10.1136/egastro-2023-100007)
ORCID
33.56 21
7 New therapeutic target for alcohol-associated hepatitis (AH)… (10.1136/egastro-2024-100166)
Abstract
32.53 19
8 Risk factors of primary liver cancer initiation associated w… (10.1136/egastro-2023-100010)
ORCID
31.38 17
9 Perspectives of mitochondria-lysosome-related organelle in h… (10.1136/egastro-2023-100046)
Abstract
30.10 15
10 Spleen stiffness measurement as a non-invasive assessment in… (10.1136/egastro-2023-100031)
ORCID
27.85 12
11 Attention to the misuse of Mendelian randomisation in medica… (10.1136/egastro-2025-100187)
Abstract
27.85 12
12 Evidence-based incorporation of key parameters into MELD sco… (10.1136/egastro-2024-100101)
ORCID
26.03 10
13 Macrophages clear out necrotic liver lesions: a new magic tr… (10.1136/egastro-2023-100024)
Abstract
22.58 7
14 Burden of digestive system malignancies and its impact on li… (10.1136/egastro-2024-100148)
Abstract
21.13 6
15 Rare cause of recurrent acute pancreatitis in teenage man (10.1136/egastro-2024-100105)
Abstract
19.45 5
16 Contribution of colibactin-producing <i>Escherichia coli</i>… (10.1136/egastro-2024-100177)
Abstract
15.05 3
17 Multimodal decoding of human liver regeneration uncovers nov… (10.1136/egastro-2025-100205)
Abstract
11.93 2
18 Blood microbial DNA signature differentiates hepatocellular… (10.1136/egastro-2025-100193)
Abstract
7.53 1
19 Megamitochondria in alcohol-associated liver disease and can… (10.1136/egastro-2026-100408)
Abstract
7.53 1
20 A star is born: <i>eGastroenterology</i> (10.1136/egastro-2023-000001)
Abstract References ORCID
0.00 0
21 Taking science to cholera in Bangladesh: the personal odysse… (10.1136/egastro-2023-000002)
ORCID
0.00 0
22 PFDN6 contributes to colorectal cancer progression via trans… (10.1136/egastro-2023-100001)
0.00 1
23 Application of artificial intelligence in the diagnosis of h… (10.1136/egastro-2023-100002)
0.00 17
24 Aetiology, diagnosis and management for ischaemic cholecysti… (10.1136/egastro-2023-100004)
0.00 3
25 Metabolic dysfunction-associated fatty liver disease increas… (10.1136/egastro-2023-100005)
0.00 22
26 Pathogenesis and precision medicine for predicting response… (10.1136/egastro-2023-100006)
0.00 28
27 Novel online calculator to predict reduced risk of early rec… (10.1136/egastro-2023-100008)
0.00 12
28 Advances in the diagnosis and management of hepatorenal synd… (10.1136/egastro-2023-100009)
0.00 9
29 Horizon scanning: new and future therapies in the management… (10.1136/egastro-2023-100012)
0.00 33
30 Alcohol-associated bowel disease: new insights into pathogen… (10.1136/egastro-2023-100013)
0.00 58
31 Revolutionary transformation lowering the mortality of pancr… (10.1136/egastro-2023-100014)
0.00 11
32 Mechanisms of liver fibrosis in metabolic syndrome (10.1136/egastro-2023-100015)
0.00 26
33 Treatment and prognosis of colorectal cancer with synchronou… (10.1136/egastro-2023-100016)
0.00 6
34 Pioneering use of genetic analysis for <i>CDH1</i> to identi… (10.1136/egastro-2023-100017)
0.00 4
35 Opportunities and challenges for hepatitis B cure (10.1136/egastro-2023-100021)
0.00 11
36 Endoscopic resection of large non-pedunculated colorectal po… (10.1136/egastro-2023-100025)
0.00 8
37 New horizons of human genetics in digestive diseases (10.1136/egastro-2023-100029)
0.00 4
38 To explore the causal association between the serum lipid pr… (10.1136/egastro-2023-100034)
0.00 4
39 CLivD score modifies FIB-4 performance in liver fibrosis det… (10.1136/egastro-2023-100035)
0.00 4
40 Prevalence and prediction of hepatocellular carcinoma in alc… (10.1136/egastro-2023-100036)
0.00 16
41 <i>ABCC2</i> p.R393W variant contributes to Dubin-Johnson sy… (10.1136/egastro-2023-100039)
0.00 2
42 Extracellular vesicles targeting non-parenchymal cells: the… (10.1136/egastro-2023-100040)
0.00 11
43 Time to treat the climate and nature crisis as one indivisib… (10.1136/egastro-2023-100041)
Abstract ORCID
0.00 0
44 Incorporating biological and clinical insights into variant… (10.1136/egastro-2023-100042)
0.00 51
45 Treatment of cholangiocarcinoma in patients with primary scl… (10.1136/egastro-2023-100045)
0.00 12
46 Prebiotic selection influencing inflammatory bowel disease t… (10.1136/egastro-2023-100055)
0.00 22
47 Recent insights about autophagy in pancreatitis (10.1136/egastro-2023-100057)
0.00 29
48 Mendelian randomisation analysis for intestinal disease: ach… (10.1136/egastro-2023-100058)
0.00 7
49 Environmental PM<sub>2.5</sub>-triggered stress responses in… (10.1136/egastro-2024-100063)
0.00 13
50 Characterisation of HBV and co-infection with HDV and HIV th… (10.1136/egastro-2024-100067)
0.00 13